257 related articles for article (PubMed ID: 18025535)
1. NF-kappaB is a key mediator of cerebral aneurysm formation.
Aoki T; Kataoka H; Shimamura M; Nakagami H; Wakayama K; Moriwaki T; Ishibashi R; Nozaki K; Morishita R; Hashimoto N
Circulation; 2007 Dec; 116(24):2830-40. PubMed ID: 18025535
[TBL] [Abstract][Full Text] [Related]
2. Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway.
Aoki T; Kataoka H; Ishibashi R; Nakagami H; Nozaki K; Morishita R; Hashimoto N
Neurosurgery; 2009 Feb; 64(2):357-65; discussion 365-6. PubMed ID: 19190463
[TBL] [Abstract][Full Text] [Related]
3. Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB.
Aoki T; Kataoka H; Ishibashi R; Nozaki K; Morishita R; Hashimoto N
Arterioscler Thromb Vasc Biol; 2009 Jul; 29(7):1080-6. PubMed ID: 19359664
[TBL] [Abstract][Full Text] [Related]
4. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment.
Aoki T; Kataoka H; Nishimura M; Ishibashi R; Morishita R; Miyamoto S
Neurosurgery; 2012 Jun; 70(6):1534-43; discussion 1543. PubMed ID: 22186838
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 4 expression during cerebral aneurysm formation. Laboratory investigation.
Aoki T; Nishimura M; Ishibashi R; Kataoka H; Takagi Y; Hashimoto N
J Neurosurg; 2010 Oct; 113(4):851-8. PubMed ID: 19852543
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage.
Ma CX; Yin WN; Cai BW; Wu J; Wang JY; He M; Sun H; Ding JL; You C
Chin Med J (Engl); 2009 Jul; 122(13):1575-81. PubMed ID: 19719951
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of apolipoprotein E deficiency in cerebral aneurysm formation.
Aoki T; Moriwaki T; Takagi Y; Kataoka H; Yang J; Nozaki K; Hashimoto N
Int J Mol Med; 2008 Apr; 21(4):453-9. PubMed ID: 18360691
[TBL] [Abstract][Full Text] [Related]
8. Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy.
Aoki T; Nishimura M
Expert Opin Ther Targets; 2010 Mar; 14(3):265-73. PubMed ID: 20128708
[TBL] [Abstract][Full Text] [Related]
9. Protective role of NF-kappaB1 (p50) in experimental pneumococcal meningitis.
Kastenbauer S; Koedel U; Weih F; Ziegler-Heitbrock L; Pfister HW
Eur J Pharmacol; 2004 Sep; 498(1-3):315-8. PubMed ID: 15364010
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.
Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK
Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappaB pathway.
Sarkar D; Saha P; Gamre S; Bhattacharjee S; Hariharan C; Ganguly S; Sen R; Mandal G; Chattopadhyay S; Majumdar S; Chatterjee M
Int Immunopharmacol; 2008 Sep; 8(9):1264-71. PubMed ID: 18602073
[TBL] [Abstract][Full Text] [Related]
12. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
13. Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation.
Aoki T; Kataoka H; Ishibashi R; Nozaki K; Egashira K; Hashimoto N
Stroke; 2009 Mar; 40(3):942-51. PubMed ID: 19164781
[TBL] [Abstract][Full Text] [Related]
14. A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
Hoffmann F; Sass G; Zillies J; Zahler S; Tiegs G; Hartkorn A; Fuchs S; Wagner J; Winter G; Coester C; Gerbes AL; Vollmar AM
Gut; 2009 Dec; 58(12):1670-8. PubMed ID: 19470497
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice.
Duckworth EA; Butler T; Collier L; Collier S; Pennypacker KR
Brain Res; 2006 May; 1088(1):167-75. PubMed ID: 16630592
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms.
Aoki T; Frȍsen J; Fukuda M; Bando K; Shioi G; Tsuji K; Ollikainen E; Nozaki K; Laakkonen J; Narumiya S
Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174280
[TBL] [Abstract][Full Text] [Related]
17. CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-kappaB activation.
Lee SJ; Nam WD; Na HJ; Cho YL; Ha KS; Hwang JY; Lee H; Kim SO; Kwon YG; Kim YM
Biochem Pharmacol; 2008 Jul; 76(1):79-90. PubMed ID: 18513703
[TBL] [Abstract][Full Text] [Related]
18. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
[TBL] [Abstract][Full Text] [Related]
19. [Effects of glutamine on changes of nuclear factor-kappa B in acute lipopolysaccharide lung injury: experiment with rats].
Chen XG; Bai T; Wu BY; Wang JK
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1648-50. PubMed ID: 19035109
[TBL] [Abstract][Full Text] [Related]
20. Cell death and proliferation in NF-kappaB p50 knockout mouse after cerebral ischemia.
Li J; Lu Z; Li WL; Yu SP; Wei L
Brain Res; 2008 Sep; 1230():281-9. PubMed ID: 18657523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
